Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation

Tundra lists 1 Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT03744793

Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer

This phase II trial studies how well pemetrexed and avelumab work in treating patients with MTAP-deficient urothelial cancer that has spread to other places in the body. Pemetrexed may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving pemetrexed and avelumab may work better in treating patients with MTAP-deficient urothelial cancer.

Gender: All

Ages: 18 Years - Any

Updated: 2026-01-09

1 state

Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation

Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation